Pradhan Akshyaya, Bhandari Monika, Vishwakarma Pravesh, Sethi Rishi
Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Int J Angiol. 2020 Mar;29(1):2-11. doi: 10.1055/s-0040-1701639. Epub 2020 Feb 25.
The causal linkage between triglycerides and coronary artery disease has been controversial. Most of the trials hitherto have shown marginal or no beneficial effects of reduction of triglycerides (with fibrates) on top of low-density lipoprotein (LDL) reduction. But a significant residual cardiovascular risk remains even after use of high dose of statins. Omega-3 fatty acids have been shown to reduce triglyceride levels and some old trials have shown the benefits of fish oils in reducing cardiovascular events. However, barring a few trials most of the large trials of omega-3 fatty acids are negative. Recently, few large trials have been conducted to see the effects of high dose omega-3 fatty acids on cardiovascular outcomes and some of them have shown promising results on top of LDL reduction.
甘油三酯与冠状动脉疾病之间的因果联系一直存在争议。迄今为止，大多数试验表明，在降低低密度脂蛋白（LDL）的基础上，降低甘油三酯（使用贝特类药物）的益处甚微或没有益处。但即使使用高剂量他汀类药物后，仍存在显著的残余心血管风险。ω-3脂肪酸已被证明可降低甘油三酯水平，一些早期试验表明鱼油在降低心血管事件方面有益处。然而，除了少数试验外，大多数关于ω-3脂肪酸的大型试验结果都是阴性的。最近，已经进行了一些大型试验来观察高剂量ω-3脂肪酸对心血管结局的影响，其中一些试验在降低LDL的基础上显示出了有希望的结果。
